CYBREXA THERAPEUTICS
Cybrexa Therapeutics is developing an entirely new class of small molecule DNA repair inhibitors that directly target the tumor microenvironment. This approach leverages a novel tumor-localizing peptide technology developed by an internationally recognized research laboratory at Yale. Our approach will change the paradigm of drug delivery, and it will greatly enhance the therapeutic index. It has the potential to re-define the definition of “drug-like,” which will unlock a vast array of molecules for clinical development. Our collection of tumor-localizing DNA repair inhibitors can be combined with numerous chemotherapies and also radiotherapy, allowing the safe delivery of higher drug doses, with enhanced efficacy.
CYBREXA THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2017-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.cybrexa.com
Total Employee:
1+
Status:
Active
Contact:
+1 860 717 2731
Total Funding:
44.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API Google Analytics Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Remedy Plan Therapeutics
Remedy Plan is a pre-clinical cancer therapeutics company developing first-in-class small molecule drugs that differentiate cancer cells.
Current Advisors List
Current Employees Featured
Founder
Investors List
Elm Street Ventures
Elm Street Ventures investment in Series B - Cybrexa Therapeutics
Advantage Capital
Advantage Capital investment in Series B - Cybrexa Therapeutics
HighCape Partners
HighCape Partners investment in Series B - Cybrexa Therapeutics
Cycle Venture Partners
Cycle Venture Partners investment in Series B - Cybrexa Therapeutics
HighCape Partners
HighCape Partners investment in Series B - Cybrexa Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series B - Cybrexa Therapeutics
Advantage Capital
Advantage Capital investment in Series B - Cybrexa Therapeutics
Advantage Capital
Advantage Capital investment in Debt Financing - Cybrexa Therapeutics
HighCape Partners
HighCape Partners investment in Series B - Cybrexa Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series B - Cybrexa Therapeutics
Official Site Inspections
http://www.cybrexa.com
- Host name: 172.67.158.9
- IP address: 172.67.158.9
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
